Astrocyte Senescence as a Component of Alzheimer’s Disease
Open accessThe DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Abstract
Aging is the main risk factor for Alzheimer's disease (AD); however, the aspects of the aging process that predispose the brain to the development of AD are largely unknown. Astrocytes perform a myriad of functions in the central nervous system to maintain homeostasis and support neuronal function. In vitro, human astrocytes are highly sensitive to oxidative stress and trigger a senescence program when faced with multiple types of stress. In order to determine whether senescent astrocytes appear in vivo, brain tissue from aged individuals and patients with AD was examined for the presence of senescent astrocytes using p16(INK4a) and matrix metalloproteinase-1 (MMP-1) expression as markers of senescence. Compared with fetal tissue samples (n = 4), a significant increase in p16(INK4a)-positive astrocytes was observed in subjects aged 35 to 50 years (n = 6; P = 0.02) and 78 to 90 years (n = 11; P<10(-6)). In addition, the frontal cortex of AD patients (n = 15) harbored a significantly greater burden of p16(INK4a)-positive astrocytes compared with non-AD adult control subjects of similar ages (n = 25; P = 0.02) and fetal controls (n = 4; P<10(-7)). Consistent with the senescent nature of the p16(INK4a)-positive astrocytes, increased metalloproteinase MMP-1 correlated with p16(INK4a). In vitro, beta-amyloid 1-42 (Aβ(1-42)) triggered senescence, driving the expression of p16(INK4a) and senescence-associated beta-galactosidase. In addition, we found that senescent astrocytes produce a number of inflammatory cytokines including interleukin-6 (IL-6), which seems to be regulated by p38MAPK. We propose that an accumulation of p16(INK4a)-positive senescent astrocytes may link increased age and increased risk for sporadic AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In many prevalent neurodegenerative conditions including Alzheimer's Disease, brain tissue biopsies are present with increased levels of p16INK4a- positive astrocytes, MMP-1 and IL-6”
From Redox control of senescence and age-related disease. (2017) · cites this paper as [99]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Astrocytes cultured from patients with AD express not only more of the CDKi p16 INK4A than age-matched controls, but also more MMP1 and IL-6 (57).”
From Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives (2018) · cites this paper as [57]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous studies have highlighted senescence in multiple brain cell types in AD [3, 16, 32, 52, 80].”
From Characterisation of premature cell senescence in Alzheimer's disease using single nuclear transcriptomics (2024) · cites this paper as [3]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In the context of aging and neurodegenerative disease, senescent cell accumulation has been identified in multiple cell types within the central nervous system (CNS), including neurons6,7,14,15, astrocytes16,17, microglia8,18, oligodendrocyte precursor cells19 and endothelial cells20.”
From Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial (2023) · cites this paper as [16]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Furthermore, prior research conducted on postmortem brain tissue from individuals with AD has identified senescent astrocytes16, and mouse models have demonstrated that they are cleared with senolytic treatment8,17.”
From Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial (2023) · cites this paper as [16]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 1×
“Staining for Senescence-associated b-galactosidase Senescence-associated beta-galactosidase (SA b-gal) staining was performed as previously described [62].”
MethodThe senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206 · cited 11×
“One component of the SASP present in multiple cell types is IL-6.”
BackgroundInfluentialAstrocytes: Biology and pathology
Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196 · cited 1×
“Astrocytes regulate the contents of the synaptic cleft and synaptic transmission as part of the tripartite synapse, control CNS metabolism, and maintain blood brain barrier integrity [10,11].”
BackgroundWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291 · cited 1×
“The increased dosage of synthetic versus cell-derived Ab oligomers required to trigger senescence, correlates with reports on the effects of Ab on rat hippocampal long-term potentiation [53].”
BackgroundShankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 1×
“demonstrated by the phenotypic improvement observed following the targeted removal of senescent cells in a progeroid mouse model [9].”
BackgroundInfluentialMechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580 · cited 1×
“In vitro, we found that exposure of astrocytes to Ab1–42 triggers senescence and that senescent astrocytes produce high quantities of interleukin-6 (IL-6), a cytokine known to be increased in the CNS of AD patients [18].”
Background2013 Alzheimer's disease facts and figures
Alzheimer's Association, Thies, W., & Bleiler, L. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.02.003 · Cited by 3,328
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168 · cited 1×
“We selected the age ranges of 35–50 years and 78–90 years (Figure 3B) in order to compare a group that is least likely to have AD and a group that is most likely to have AD [31].”
MethodBRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Cited by
Items 101–200 of 589
Sympathetic nervous system as a target for aging and obesity-related cardiovascular diseases
Balasubramanian, P., Hall, D., & Subramanian, M. (2018) · GeroScience · doi:10.1007/s11357-018-0048-5 · Cited by 118
Astrocyte and Alzheimer’s disease
Cai, Z., Wan, C., & Liu, Z. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8593-x · Cited by 136
Role of cellular senescence in inflammation and regeneration
Saito, Y., Yamamoto, S., & Chikenji, T. (2024) · Inflammation and Regeneration · doi:10.1186/s41232-024-00342-5 · Cited by 140
Evidence and perspectives of cell senescence in neurodegenerative diseases
Si, Z., Sun, L., & Wang, X. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111327 · Cited by 105
Rare Individual Amyloid-β Oligomers Act on Astrocytes to Initiate Neuronal Damage
Narayan, P., Holmström, K. M., Kim, D.-H., Whitcomb, D. J., Wilson, M. R., St. George-Hyslop, P., Wood, N. W., Dobson, C. M., Cho, K., Abramov, A. Y., et al. (2014) · Biochemistry · doi:10.1021/bi401606f · Cited by 103
Xu, X., Shen, X., Wang, J., Feng, W., Wang, M., Miao, X., Wu, Q., Wu, L., Wang, X., Ma, Y., et al. (2021) · Aging Cell · doi:10.1111/acel.13465 · Cited by 103
“Interestingly, beta- amyloid triggered senescence of astrocytes in vitro, which implied mutual promotion of astrocyte senescence and beta- amyloid deposition (Bhat et al., 2012).”
BackgroundSleep and immune function: glial contributions and consequences of aging
Ingiosi, A. M., Opp, M. R., & Krueger, J. M. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.02.003 · Cited by 103
Alzheimer’s Disease: Mechanism and Approach to Cell Therapy
Amemori, T., Jendelova, P., Ruzicka, J., Urdzikova, L., & Sykova, E. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125961 · Cited by 102
“Although DNA damage in the hippocampal astrocytes of AD brains and an increased population of astrocytes from the frontal cortex of aged individuals and AD patients have been reported [272,273], further intensive studies are required to elucidate their causal relationship to AD pathogenesis and development and to use…”
BackgroundCellular Senescence and Iron Dyshomeostasis in Alzheimer’s Disease
Masaldan, S., Belaidi, A. A., Ayton, S., & Bush, A. I. (2019) · Pharmaceuticals · doi:10.3390/ph12020093 · Cited by 102
“In the context of AD, astrocytes expressing p16INK4A are enriched in the frontal cortex of AD patients compared to age-matched non-AD adults [87].”
BackgroundA clinical primer for the glymphatic system
Carlstrom, L. P., Eltanahy, A. M., Perry, A., Rabinstein, A. A., Elder, B. D., Morris, J. M., Meyer, F. B., Graffeo, C. S., Lundgaard, I., & Burns, T. C. (2021) · Brain · doi:10.1093/brain/awab428 · Cited by 107
Fate of microglia during HIV‐1 infection: From activation to senescence?
Chen, N. C., Partridge, A. T., Sell, C., Torres, C., & Martín‐García, J. (2017) · Glia · doi:10.1002/glia.23081 · Cited by 95
“More specifically, senescent phenotypes have been observed in various cell types residing in different tissues including bronchial cells, adipocytes and pancreatic b cells, as well as in astrocytes, and development of senescence in those cells has been shown to contribute to and/or to be associated with the onset of p…”
BackgroundSelf-citationGlaucoma: from pathogenic mechanisms to retinal glial cell response to damage
Fernández‐Albarral, J. A., Ramirez, A. I., de Hoz, R., Matamoros, J. A., Salobrar‐García, E., Elvira‐Hurtado, L., López‐Cuenca, I., Sánchez-Puebla, L., Salazar, J. J., & Ramirez, J. M. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1354569 · Cited by 116
Bioenergetic Mechanisms in Astrocytes May Contribute to Amyloid Plaque Deposition and Toxicity
Fu, W., Shi, D., Westaway, D., & Jhamandas, J. H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.618157 · Cited by 91
“Reactive astrogliosis is a well characterized spectrum of morphological and biochemical changes that occur in astrocytes in response to a variety of insults (35) and has also been identified in the context of stress-induced astrocyte senescence (36).”
BackgroundGlucose metabolism, neural cell senescence and Alzheimer's disease
Wang, Q., Duan, L., Li, X., Wang, Y., Guo, W., Guan, F., & Ma, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084351 · Cited by 90
“Moreover, aged or AD brain exhibited senescent astrocytes and abnormal astrocyte function [13].”
BackgroundCharacterizing the “POAGome”: A bioinformatics-driven approach to primary open-angle glaucoma
Danford, I. D., Verkuil, L. D., Choi, D. J., Collins, D. W., Gudiseva, H. V., Uyhazi, K. E., Lau, M. K., Kanu, L. N., Grant, G. R., Chavali, V. R. M., et al. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.02.001 · Cited by 90
“Second, it stifles the population of neurosupportive glia, such as astrocytes and retinal Müller glia, by impairing their function and halting their entry into the cell cycle (Bhat et al., 2012; Lindholm et al., 1992).”
BackgroundWei, Z., Chen, X.-C., Song, Y., Pan, X.-D., Dai, X.-M., Zhang, J., Cui, X.-L., Wu, X.-L., & Zhu, Y.-G. (2016) · Chinese Medical Journal · doi:10.4103/0366-6999.186646 · Cited by 89
“This finding was consistent with the previous observations that p16 was co‐localized with PHFs in AD brains[18] and that p16 was expressed in senescent astrocytes.[21,29]”
BackgroundResultMicroglia–Astrocyte Interaction in Neural Development and Neural Pathogenesis
Sun, M., You, H., Hu, X., Luo, Y., Zhang, Z., Song, Y., An, J., & Lü, H. (2023) · Cells · doi:10.3390/cells12151942 · Cited by 98
HIV-associated cellular senescence: A contributor to accelerated aging
Cohen, J., & Torres, C. A. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.12.004 · Cited by 100
“Senescence in the CNS is a novel concept but emerging evidence suggests that CNS senescence may contribute to neurological disorders (Bhat et al., 2012; Wan et al., 2014a).”
Self-citationMyeloid-derived suppressor cells (MDSC): an important partner in cellular/tissue senescence
Salminen, A., Kauppinen, A., & Kaarniranta, K. (2018) · Biogerontology · doi:10.1007/s10522-018-9762-8 · Cited by 84
Trias, E., Beilby, P. R., Kovacs, M., Ibarburu, S., Varela, V., Barreto-Núñez, R., Bradford, S. C., Beckman, J. S., & Barbeito, L. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00042 · Cited by 85
Non-coding RNA in neural function, disease, and aging
Szafranski, K. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00087 · Cited by 85
“This may contribute to disease as these astrocytes have a senescenceassociated secretory phenotype wherein they release inflammatory cytokines such as IL-6 (Bhat et al., 2012).”
BackgroundPreininger, M. K., & Kaufer, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116217 · Cited by 92
Cellular Senescence as a Therapeutic Target for Age-Related Diseases: A Review
Amaya-Montoya, M., Pérez-Londoño, A., Guatibonza-García, V., Vargas-Villanueva, A., & Mendivil, C. O. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01287-0 · Cited by 82
Vazquez‐Villaseñor, I., Garwood, C. J., Heath, P. R., Simpson, J. E., Ince, P. G., & Wharton, S. B. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12559 · Cited by 82
Targeting neuroinflammation in Alzheimer’s disease: evidence for NSAIDs and novel therapeutics
Deardorff, W. J., & Grossberg, G. T. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1200972 · Cited by 81
Redox changes and cellular senescence in Alzheimer's disease
Yu, N., Pasha, M., & Chua, J. J. E. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103048 · Cited by 80
“Cellular senescence has been shown to play a pivotal role in the progression of AD [20,21].”
BackgroundRe-thinking the Etiological Framework of Neurodegeneration
Castillo, X., Castro-Obregón, S., Gutiérrez-Becker, B., Gutiérrez-Ospina, G., Karalis, N., Khalil, A. A., Lopez-Noguerola, J. S., Rodríguez, L. L., Martínez-Martínez, E., Perez-Cruz, C., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00728 · Cited by 79
Aging, Cellular Senescence, and Progressive Multiple Sclerosis
Papadopoulos, D., Magliozzi, R., Mitsikostas, D. D., Gorgoulis, V. G., & Nicholas, R. S. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00178 · Cited by 79
“Senescent astrocytes expressing P16INK4A and secreting metalloproteinase-1 (MMP1) have been found in post-mortem tissues of Alzheimer’s disease patients (Bhat et al., 2012).”
BackgroundEvidence of sex differences in cellular senescence
Ng, M., & Hazrati, L.-N. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.08.014 · Cited by 78
Das, M. M., & Svendsen, C. N. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.09.020 · Cited by 79
Human Alzheimer’s disease reactive astrocytes exhibit a loss of homeostastic gene expression
Dai, D. L., Li, M., & Lee, E. B. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01624-8 · Cited by 77
“Astrocytes have been shown to take on a senescence phenotype following treatment with amyloid-beta oligomers [4, 18], and astrocytes expressing the senescent markers p16INK4a and IL-6 have been found in the frontal cortex of aged patients, Alzheimer’s disease patients, and around amyloid plaques [4, 14].”
BackgroundTing, K. K., Coleman, P., Kim, H. J., Zhao, Y., Mulangala, J., Cheng, N. C., Li, W., Gunatilake, D., Johnstone, D. M., Loo, L., et al. (2023) · GeroScience · doi:10.1007/s11357-023-00927-x · Cited by 76
Interaction of astrocytes and T cells in physiological and pathological conditions
Xie, L., & Yang, S. (2015) · Brain Research · doi:10.1016/j.brainres.2015.03.026 · Cited by 93
A stocked toolbox for understanding the role of astrocytes in disease
Almad, A., & Maragakis, N. J. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0010-2 · Cited by 86
Willis, C. M., Nicaise, A. M., Bongarzone, E. R., Givogri, M., Reiter, C. R., Heintz, O., Jellison, E. R., Sutter, P. A., TeHennepe, G., Ananda, G., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-57663-x · Cited by 76
Váňová, T., Sedmík, J., Raška, J., Černá, K. A., Tauš, P., Pospisilova, V., Nezvedová, M., Fedorová, V., Kadakova, S., Klímová, H., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113310 · Cited by 86
Salminen, A. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101280 · Cited by 73
Neuroimmune contributions to Alzheimer’s disease: a focus on human data
Haage, V., & De Jager, P. L. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01637-0 · Cited by 74
“Using p16 as a marker for cellular senescence, a study identified a significant population of p16 positive astrocytes in the frontal cortex of AD patients when compared to age-matched non-AD control subjects, suggesting a link between increased age of astrocytes and risk for sporadic AD [236].”
ResultCellular senescence in age-related disorders
Kaur, J., & Farr, J. N. (2020) · Translational research · doi:10.1016/j.trsl.2020.06.007 · Cited by 85
Issitt, T., Bosseboeuf, E., de Winter, N., Dufton, N., Gestri, G., Senatore, V., Chikh, A., RANDI, A. M., & Raimondi, C. (2018) · iScience · doi:10.1016/j.isci.2018.12.005 · Cited by 77
Astrocyte senescence and SASP in neurodegeneration: tau joins the loop
Ungerleider, K., Beck, J., Lissa, D., Turnquist, C., Horikawa, I., Harris, B. T., & Harris, C. C. (2021) · Cell Cycle · doi:10.1080/15384101.2021.1909260 · Cited by 71
“Previously, we and others have shown increased numbers of senescent cells, including senescent astrocytes, in brain tissues from patients with neurodegenerative tauopathies [8,25,27,70].”
BackgroundCellular senescence in brain aging and cognitive decline
Shafqat, A., Khan, S., Omer, M. H., Niaz, M., Albalkhi, I., AlKattan, K. M., Yaqinuddin, A., Tchkonia, T., Kirkland, J. L., & Hashmi, S. K. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1281581 · Cited by 86
Aging Fits the Disease Criteria of the International Classification of Diseases
Khaltourina, D. A., Matveyev, Y., Alekseev, A., Cortese, F., & Ioviţă, A. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111230 · Cited by 85
Roles of Cytokines in Alzheimer’s Disease
Chen, Z., Balachandran, Y. L., Chong, W. P., & Chan, K. W. Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115803 · Cited by 81
“Several studies have reported the accumulation of senescent cells in the AD brain [49,96].”
BackgroundMária, J., & Ingrid, Ž. (2017) · Food & Function · doi:10.1039/c7fo00161d · Cited by 71
Misawa, T., Tanaka, Y., Okada, R., & Takahashi, A. (2020) · Geriatrics & Gerontology International · doi:10.1111/ggi.13928 · Cited by 69
Cellular senescence: a view throughout organismal life
von Kobbe, C. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2879-8 · Cited by 76
Basisty, N., Kale, A., Patel, S., Campisi, J., & Schilling, B. (2020) · Expert Review of Proteomics · doi:10.1080/14789450.2020.1766976 · Cited by 69
Phenotypic and functional differences between senescent and aged murine microglia
Stojiljkovic, M. R., Ain, Q., Bondeva, T., Heller, R., Schmeer, C., & Witte, O. W. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.10.007 · Cited by 71
Viejo, L., Noori, A., Merrill, E., Das, S., Hyman, B. T., & Serrano‐Pozo, A. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12753 · Cited by 69
“Extracellular matrix Reactive astrocytes in AD also play an essential role in reorganisation of the extracellular matrix, as judged by their increased immunoreactivity for secreted proteases such as the matrix metalloproteinases interstitial collagenase (MMP1) [112] and stromelysin-1 (MMP3) [113] as well as urokinase-…”
BackgroundInfluentialUntangling senescent and damage‐associated microglia in the aging and diseased brain
Ng, P. Y., McNeely, T. L., & Baker, D. J. (2023) · The FEBS Journal · doi:10.1111/febs.16315 · Cited by 68
Cao, L., Wang, H., Wang, F., Xu, D., Liu, F., & Liu, C. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-11612 · Cited by 68
Therapeutic targeting of senescent cells in the CNS
Riessland, M., Ximerakis, M., Jarjour, A. A., Zhang, B., & Orr, M. E. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01033-z · Cited by 77
“Later discoveries of senescent-like neurons 7–10 and astrocytes 11,12 in post-mortem tissue from patients with Alzheimer disease (AD) and Parkinson disease supported the initial findings and highlighted the potential translational importance of senescent cells in the brain.”
Kiss, T., Nyúl-Tóth, Á., DelFavero, J., Balasubramanian, P., Tarantini, S., Faakye, J., Gulej, R., Ahire, C., Ungvari, A., Yabluchanskiy, A., et al. (2022) · GeroScience · doi:10.1007/s11357-022-00521-7 · Cited by 66
“Astrocyte senescence likely impair many of the aforementioned neuroprotective functions, contributing to the development of brain aging phenotypes and the pathogenesis of neurodegenerative diseases [27, 46, 91, 92].”
BackgroundCellular senescence in Alzheimer’s disease: from physiology to pathology
Zhu, J., Wu, C., & Yang, L. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00447-4 · Cited by 78
Ginsenoside F1 suppresses astrocytic senescence-associated secretory phenotype
Hou, J., Cui, C.-H., Kim, S., Sung, C. K., & Choi, C. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.02.002 · Cited by 70
Cell Senescence, Multiple Organelle Dysfunction and Atherosclerosis
Machado-Oliveira, G., Ramos, C., Marques, A. R. A., & Vieira, O. V. (2020) · Cells · doi:10.3390/cells9102146 · Cited by 80
Senescence in tissue samples of humans with age-related diseases: A systematic review
Tuttle, C. S. L., Luesken, S. W. M., Waaijer, M. E. C., & Maier, A. B. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101334 · Cited by 64
“All articles (Al-Mashhadi et al., 2015; Bhat et al., 2012; Chinta et al., 2018; Garwood et al., 2014; Musi et al., 2018; Nicaise et al., 2019; Schaser et al., 2019; Shanbhag et al., 2019; Turnquist et al., 2016; Vazquez-Villasenor et al., 2019), except one (Sorensen et al.”
Unique signatures of stress-induced senescent human astrocytes
Simmnacher, K., Krach, F., Schneider, Y., Alecu, J. E., Mautner, L., Klein, P., Roybon, L., Prots, I., Xiang, W., & Winner, B. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113466 · Cited by 72
Glia in Neurodegeneration: The Housekeeper, the Defender and the Perpetrator
Sheeler, C. A., Rosa, J. S., Ferro, A., McAdams, B. D., Borgenheimer, E., & Cvetanović, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239188 · Cited by 63
“The percentage of senescent astrocytes, marked by p16 expression, increases with aging and is further increased in Alzheimer’s disease [89].”
BackgroundSenescence as an Amyloid Cascade: The Amyloid Senescence Hypothesis
Walton, C. C., Begelman, D., Nguyen, W., & Andersen, J. K. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00129 · Cited by 62
Bientinesi, E., Lulli, M., Becatti, M., Ristori, S., Margheri, F., & Monti, D. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111689 · Cited by 61
Positive and negative effects of cellular senescence during female reproductive aging and pregnancy
Velarde, M. C., & Menon, R. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0018 · Cited by 61
The Emerging Role of Senescence in Ocular Disease
Sreekumar, P. G., Hinton, D. R., & Kannan, R. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2583601 · Cited by 61
The Role of Glial Cell Senescence in Alzheimer's Disease
Alshaebi, F., Sciortino, A., & Kayed, R. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70051 · Cited by 60
“Increased levels of p16 INK4A and the DNA damage marker γH2AX have been observed in cortical astrocytes of ad patients (Bhat et al. 2012; Gaikwad et al. 2021), and elevated levels of HMGB1 in astrocytes have been associated with the presence of tau oligomers (Gaikwad et al. 2021).”
The multimodal action of genistein in Alzheimer's and other age-related diseases
Mas‐Bargues, C., Borrás, C., & Viña, J. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.03.021 · Cited by 84
Astrocyte senescence and metabolic changes in response to HIV antiretroviral therapy drugs
Cohen, J., D’Agostino, L., Wilson, J., Tuzer, F., & Torres, C. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00281 · Cited by 58
“In concordance, we have previously demonstrated astrocyte senescence in association between AD (Bhat et al., 2012).”
BackgroundSelf-citationYu, C., Narasipura, S. D., Richards, M. H., Hu, X., Yamamoto, B., & Al‐Harthi, L. (2017) · Aging Cell · doi:10.1111/acel.12593 · Cited by 57
“Astrocyte senescence is implicated in human brain aging (Kang et al., 2015) and in neurodegenerative diseases such as Alzheimer’s (Bhat et al., 2012) and Parkinson’s disease (Chinta et al., 2013).”
BackgroundInfluentialYabluchanskiy, A., Nyúl‐Tóth, Á., Csiszár, A., Gulej, R., Saunders, D., Towner, R. A., Turner, M. P., Zhao, Y., Abdelkari, D., Rypma, B., et al. (2020) · Psychophysiology · doi:10.1111/psyp.13718 · Cited by 62
Ionizing Radiation-Induced Brain Cell Aging and the Potential Underlying Molecular Mechanisms
Wang, Q., Yin, G., Huang, J., Xi, S.-J., Qian, F., Lee, R.-X., Peng, X., & Tang, F. R. (2021) · Cells · doi:10.3390/cells10123570 · Cited by 64
“With age, the number of astrocytes expressing p16INK4a and MMP3 (protease closely associated with the senescence-associated secretion phenotype) increases [72].”
BackgroundSimpson, J. E., Ince, P. G., Matthews, F. E., Shaw, P. J., Heath, P. R., Brayne, C., Garwood, C., Higginbottom, A., Wharton, S. B., & MRC Cognitive Function and Ageing Neuropathology Study Group (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12202 · Cited by 56
Targeting normal and cancer senescent cells as a strategy of senotherapy
Sikora, E., Bielak-Zmijewska, A., & Mosieniak, G. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100941 · Cited by 56
Reactive and Senescent Astroglial Phenotypes as Hallmarks of Brain Pathologies
Lazic, A., Balint, V., Ninković, D. S., Perić, M., & Stevanović, M. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094995 · Cited by 65
An update on potential links between type 2 diabetes mellitus and Alzheimer’s disease
Sousa, R. A. L. D., Harmer, A. R., Freitas, D. A., Mendonça, V. A., Lacerda, A. C. R., & Leite, H. R. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05693-z · Cited by 64
Longitudinal Changes in Resting Metabolic Rates with Aging Are Accelerated by Diseases
Zampino, M., AlGhatrif, M., Kuo, P.-L., Simonsick, E. M., & Ferrucci, L. (2020) · Nutrients · doi:10.3390/nu12103061 · Cited by 63
Labarta-Bajo, L., & Allen, N. J. (2025) · Neuron · doi:10.1016/j.neuron.2024.12.010 · Cited by 69
Okoreeh, A. K., Bake, S., & Sohrabji, F. (2017) · Glia · doi:10.1002/glia.23142 · Cited by 55
“Similarly, while astrocytes normally release a variety of trophic factors that promote neuronal survival and curb CNS degeneration (Ridet, Malhotra, Privat, & Gage, 1997) including insulin like growth factor (IGF)21 and VEGF (Chisholm & Sohrabji, 2016), these secretions decrease with age (Bhat et al., 2012; Lewis et a…”
BackgroundSah, E., Krishnamurthy, S., Ahmidouch, M. Y., Gillispie, G. J., Milligan, C., & Orr, M. E. (2021) · Life · doi:10.3390/life11030229 · Cited by 55
“Astrocyte senescence increases with age in the human brain and in AD [127,128] and PD [129].”
BackgroundKanthasamy, A., Jin, H., Charli, A., Anantharam, V., & Kanthasamy, A. G. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.01.001 · Cited by 61
Innate immunity and cellular senescence: The good and the bad in the developmental and aged brain
Santoro, A., Spinelli, C. C., Martucciello, S., Nori, S. L., Capunzo, M., Puca, A. A., & Ciaglia, E. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0118-003r · Cited by 50
The struggle of a good friend getting old: cellular senescence in viral responses and therapy
Kohli, J., Veenstra, I., & Demaria, M. (2021) · The EMBO Reports · doi:10.15252/embr.202052243 · Cited by 52
“:3) evre et al , 2010; Hernandez-Vallejo et al , 2013; Auclair et al , 2014; Bonello-Palot et al , 2014; Afonso et al , 2017).”
Guan, L., Crasta, K., & Maier, A. B. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101634 · Cited by 57
“, 2019), although p16 protein was shown to be higher in cortex astrocytes from AD patients (Bhat et al., 2012).”
BackgroundTranslating the Biology of Aging into New Therapeutics for Alzheimer's Disease: Senolytics
Riessland, M., & Orr, M. E. (2023) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2023.104 · Cited by 52
“…with advanced age and contributes to Alzheimer’s disease Multiple brain cell types have been identified to enter cellular senescence with advanced aging and/or AD including astrocytes (38), microglia (40), OPCs (37), neurons (35, 39), endothelial cells (41), and smooth muscle vascular cells (42).”
BackgroundSubretinal injection of amyloid-β peptide accelerates RPE cell senescence and retinal degeneration
Liu, C., Cao, L., Yang, S., Xu, L., Liu, P., Wang, F., & Xu, D. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1993 · Cited by 53
Testing Aβ toxicity on primary CNS cultures using drug-screening microfluidic chips
Ruiz, A., Joshi, P., Mastrangelo, R., Francolini, M., Verderio, C., & Matteoli, M. (2014) · Lab on a Chip · doi:10.1039/c4lc00174e · Cited by 56
Physical exercise protocols in animal models of Alzheimer’s disease: a systematic review
Sousa, R. A. L. D., Rodrigues, C. M., Mendes, B. F., Caria, A. C. I., Dias‐Peixoto, M. F., & Cassilhas, R. C. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00633-z · Cited by 55
“Astrocytes and microglial activation trigger inflammatory pathways that lead to insulin resistance in AD (Soreq et al. 2017; Bhat et al. 2012).”
BackgroundIs Beta-Amyloid Accumulation a Cause or Consequence of Alzheimer's Disease?
Wang, S., Mims, P. N., Roman, R. J., & Fan, F. (2016) · PubMed · Cited by 63
Astrocyte senescence contributes to cognitive decline
Csípő, T., Lipécz, Á., Ashpole, N. M., Balasubramanian, P., & Tarantini, S. (2019) · GeroScience · doi:10.1007/s11357-019-00140-9 · Cited by 53
Drugs Modulating CD4+ T Cells Blood–Brain Barrier Interaction in Alzheimer’s Disease
Kubick, N., Flournoy, P. C. H., Enciu, A., Mickael, M., & Manda, G. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090880 · Cited by 50
DPP4 inhibition impairs senohemostasis to improve plaque stability in atherosclerotic mice
Herman, A. B., Tsitsipatis, D., Anerillas, C., Mazan-Mamczarz, K., Carr, A. E., Gregg, J. M., Wang, M., Zhang, J., Michel, M., Henry-Smith, C. A., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci165933 · Cited by 50
“Although senescent cells possess the ability to be both beneficial and harmful depending on the biological situation, there is little doubt that the accrual of senescent cells in older human tissues is detrimental and contributes to pathologies associated with aging (7–9).”
Fancy, N. N., Smith, A. M., Caramello, A., Tsartsalis, S., Davey, K., Muirhead, R. C. J., McGarry, A., Jenkyns, M. H., Schneegans, E., Chau, V., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02727-9 · Cited by 48
“Aβ 1–42 can induce senescence in astrocytes in vitro and greater numbers of p16-positive astrocytes have been reported in the frontal cortex of AD patients compared to that from non-diseased control brains [3].”
BackgroundAre skin senescence and immunosenescence linked within individuals?
Waaijer, M. E. C., Goldeck, D., Gunn, D. A., van Heemst, D., Westendorp, R. G. J., Pawelec, G., & Maier, A. B. (2019) · Aging Cell · doi:10.1111/acel.12956 · Cited by 48
“These senescent cells might contrib‐ ute to the aging process, as they are associated with age‐related pathol‐ ogy (Bhat et al., 2012; Verzola et al., 2008).”
BackgroundRegulatory mechanisms and clinical manifestations of musculoskeletal aging
Grote, C. W., Reinhardt, D., Zhang, M., & Wang, J. (2019) · Journal of Orthopaedic Research® · doi:10.1002/jor.24292 · Cited by 63
From cellular senescence to age-associated diseases: the miRNA connection
Schraml, E., & Grillari, J. (2012) · Longevity & Healthspan · doi:10.1186/2046-2395-1-10 · Cited by 47
Hampel, H., Lista, S., Neri, C., & Vergallo, A. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101662 · Cited by 47
Aging, Senescence, and Dementia
Behfar, Q., Zuniga, A. R., & Adami, P. V. M. (2022) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2022.42 · Cited by 58
Inflammaging, cellular senescence, and cognitive aging after traumatic brain injury
Lu, Y., Jarrahi, A., Moore, N. D., Bartoli, M., Brann, D. W., Baban, B., & Dhandapani, K. M. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106090 · Cited by 54
“Astrocytes acquire a senescent phenotype in Alzheimer’s disease patients while genetic clearance of senescent glia reduced gliosis, tau accumulation, and preserved cognitive function in a pre-clinical model of tauopathy (Bhat et al., 2012; Bussian et al., 2018).”
BackgroundRichardson, M., & Richardson, D. R. (2023) · Molecular Pharmacology · doi:10.1124/molpharm.123.000803 · Cited by 51
Immunity and Alzheimer's disease: immunological perspectives on the development of novel therapies
Liu, Y.-H., Zeng, F., Wang, Y., Zhou, H., Giunta, B. N., Tan, J., & Wang, Y. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.07.020 · Cited by 49
Identification of distinct and age‐dependent p16High microglia subtypes
Talma, N., Gerrits, E., Wang, B., Eggen, B. J. L., & Demaria, M. (2021) · Aging Cell · doi:10.1111/acel.13450 · Cited by 46
Metadata
- Authors
- Bhat, R., Crowe, E. P., Bitto, A., Moh, M., Katsetos, C. D., Garcia, F. U., Johnson, F. B., Trojanowski, J. Q., Sell, C., & Torres, C.
- Affiliations
- Drexel University (US)
- University of Pennsylvania (US)
- Corresponding author
- Torres, Claudio
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-09-12
- Volume
- 7
- Issue
- 9
- Pages
- e45069
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3440417
- OpenAlex
- W2026433865
- Cited by
- 586
- References
- 64
- Citations by year
- 2026: 44 · 2025: 56 · 2024: 68 · 2023: 54 · 2022: 52 · 2021: 59 · 2020: 53 · 2019: 47 · 2018: 37 · 2017: 27 · 2016: 31 · 2015: 17 · 2014: 30 · 2013: 7 · 2012: 3
- FWCI
- 12.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Drexel University
- National Institutes of Health
- University of California, San Diego
- College of Medicine, Drexel University
- National Institute on Aging (AG022443-S1, AG022443, R01AG022443)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- astrocyte senescence, Alzheimer's disease, aging, p16INK4a, MMP-1, amyloid-beta 42, oxidative stress, senescence-associated β-galactosidase, interleukin-6, p38 MAPK, neuroinflammation, frontal cortex, sporadic Alzheimer's disease
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alzheimer Disease, Animals, Astrocytes, Brain, Cells, Cultured, Cricetulus, Female, Cricetinae, Humans, Male, Microscopy, Fluorescence, Middle Aged, Peptide Fragments, Immunoblotting, Biomarkers, Interleukin-6, Amyloid beta-Peptides, CHO Cells, Cellular Senescence, Cyclin-Dependent Kinase Inhibitor p16, Matrix Metalloproteinase 1, p38 Mitogen-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.